Dr. Mohammad Yaser Abajy
Academic Qualification:
- Research Fellowship from University of Graz, Institute of Molecular Biosciences, Graz, Austria.
- PhD Degree from Technical University of Berlin with an Excellent grade.
Doctoral Dissertation Title:
Molecular Biological and Biochemical Studies of a Type IV Secretion-Like System (T4SLS) Encoded on the Plasmid (pIP501), Responsible for the Transfer of Antibiotic Resistance in Enterococci. - Bachelor’s Degree in Pharmacy and Pharmaceutical Chemistry (Industrial Specialization) from University of Aleppo with a Very Good grade.
Contact
- mohammad.yaser.abajy@ebla.edu.sy
Experiences:
Professional Experience:
- Dean of the Faculty of Pharmacy at University of Aleppo.
- Assistant Professor at University of Aleppo, Faculty of Pharmacy, Department of Biochemistry and Microbiology (since 2016).
- Lecturer at Ebla Private University, Faculty of Pharmacy, Department of Biochemistry and Microbiology (since 2013).
Previous Administrative Positions:
- Head of the Department of Pharmacology and Toxicology (2020–2024).
- Vice Dean of the Faculty of Pharmacy for Administrative Affairs (2017–2021).
- Vice Dean of the Faculty of Pharmacy for Academic Affairs (2016–2017).
- Vice Dean of the Faculty of Pharmacy for Administrative Affairs (2014–2016).
- Head of the Teachers’ Union Unit Office (2012–2015).
- Teaching Assistant at University of Aleppo, Faculty of Pharmacy, Department of Biochemistry and Microbiology
(from May 2001 to August 2002). - Head of the Tablets and Capsules Department at Kimi Pharmaceutical Factory, in addition to working in the Research and Development Department, Aleppo – Al-Mansoura
(from August 1999 to August 2002).
Associations and Professional Memberships:
- Member of the Syrian German Medical Association (SGMA).
- Member of the Teachers Syndicate.
- Former Member of the Austrian Society for Biochemistry and Molecular Biology.
- Former Member of the Association for General and Applied Microbiology.
- Former Member of the American Society for Microbiology.
Teaching Courses:
- Molecular Biology for fourth-year students (theoretical and practical).
- Pharmaceutical Biotechnology for fifth-year students (theoretical).
- Pharmaceutical Microbiology for fifth-year students (theoretical and practical).
- Pharmacology (1) for third-year students (theoretical and practical).
- Pharmacology (3) for fourth-year students (theoretical).
- Pharmacology for Master’s students in Pharmaceutical Chemistry (theoretical).
- English for Specific Purposes (3) for second-year students.
- Cell Biology for preparatory medical-year students (theoretical and practical).
- Medical Genetics for preparatory medical-year students (theoretical only).
Researches:
Anti inflammatory properties and safety of green synthesized metal and metal oxidenanoparticles: A review article
NSAIDs, glucocorticoids, aminosalicylates, and immunosuppressants are nowadays the most commonly used anti-inflammatory medicines, although they have cosiderable side effects. Nanoparticles (NPs), notably metallic NPs, have gained appeal in the development of safer anti-inflammatory drugs. Because conventional NP synthesis methods are limited by environmentally unfriendly chemicals and high energy consumption, alternative green synthesis of metallic and metal oxide NPs, including plant-mediated synthesis, has piqued the interest of researchers due to phytochemicals that can reduce metal precursors and stabilize the generated NPs. This method is an eco-friendly, non-toxic, and cost-effective. This review aimed to highlight studies concerningthe anti- inflammatory activity of different plant-mediated green synthesis of metal and metal oxide nanoparticles with anti-inflammatory properties covering papers since 2017. According to the findings, the majority of the NPs tested were AgNPs. Noticeably, few investigations were conducted to assess the stability and safety of these NPs. Remarkably, someNPs exert more anti-inflammatory activity than plant extract itself and the standard. Some anti-inflammatory tests were limited to in vitro testing. Obviously, there is a lack of information regarding the safety issues of these NPs and the determination of their active doses. Thus, further invitro and invivo pharmacological and toxicological studiesare required for these metal and metal oxide NPs to identify medicinal uses and avoid unintended adverse consequences. It is also urgent to test the stability of these NPs in various dosage forms after determining the optimal active dose - European Journal of Medicinal Chemistry Reports
1 - May - 2024
Read More >>